Watch For Duplications on Discharge Med Lists With Soliqua and Lantus
Lixisenatide (Adlyxin) is the sixth GLP-1 agonist for diabetes. Think of it as similar to Byetta...but it's once-daily instead of BID.
Soliqua is the first insulin/GLP-1 agonist combo to hit the market. It contains insulin glargine U-100 (Lantus) plus lixisenatide.